1. Coux, O., Tanaka, K. & Goldberg, A. L. Structure and functions of the 20S and 26S proteasomes. Annu. Rev. Biochem. 65, 801–847 (1996).
2. Avram, Hershko; Aaron, C. The ubiquitin system. Annu. Rev. Biochem. 67, 425– 479 (1998).
3. Mizushima, N. & Komatsu, M. Autophagy: Renovation of cells and tissues. Cell 147, 728–741 (2011).
4. Yan, J. et al. Overexpression of Human E46K Mutant α-Synuclein Impairs Macroautophagy via Inactivation of JNK1-Bcl-2 Pathway. Mol. Neurobiol. 50, 685–701 (2014).
5. Winslow, A. R. et al. α-Synuclein impairs macroautophagy: implications for Parkinson’s disease. J. Cell Biol. 190, 1023–1037 (2010).
6. Tanik, S. A., Schultheiss, C. E., Volpicelli-Daley, L. A., Brunden, K. R. & Lee, V. M. Y. Lewy Body-like α-Synuclein Aggregates Resist Degradation and Impair Macroautophagy. J. Biol. Chem. 288, 15194–15210 (2013).
7. Song, J. et al. HMGB1 is involved in autophagy inhibition caused by SNCA/α- synuclein overexpression. Autophagy 10, 144–154 (2014).
8. Wang, K. et al. Beclin1 and HMGB1 ameliorate the α -synuclein-mediated autophagy inhibition in PC12 cells. Diagn. Pathol. 1–10 (2016). doi:10.1186/s13000-016-0459-5
9. Tseng, B. P., Green, K. N., Chan, J. L., Blurton-Jones, M. & LaFerla, F. M. Aβ inhibits the proteasome and enhances amyloid and tau accumulation. Neurobiol. Aging 29, 1607–1618 (2008).
10. Bence, N. F., Sampat, R. M. & Kopito, R. R. Impairment of the ubiquitin- proteasome system by protein aggregation. Science (80-. ). 292, 1552–5 (2001).
11. Koizumi, S. et al. The aspartyl protease DDI2 activates Nrf1 to compensate for proteasome dysfunction. Elife 5, 1–10 (2016).
12. Radhakrishnan, S. K. et al. Transcription factor Nrf1 mediates the proteasome recovery pathway after proteasome inhibition in mammalian cells. Mol. Cell 38, 17–28 (2010).
13. Steffen, J., Seeger, M., Koch, A. & Krüger, E. Proteasomal degradation is transcriptionally controlled by TCF11 via an ERAD-dependent feedback loop. Mol. Cell 40, 147–158 (2010).
14. Pandey, U. B. et al. HDAC6 rescues neurodegeneration and provides an essential link between autophagy and the UPS. Nature 447, 860–864 (2007).
15. Jiang, S. et al. Participation of proteasome-ubiquitin protein degradation in autophagy and the activation of AMP-activated protein kinase. Cell. Signal. 27, 1186–1197 (2015).
16. Min, H. et al. Bortezomib induces protective autophagy through AMP-activated protein kinase activation in cultured pancreatic and colorectal cancer cells. Cancer Chemother. Pharmacol. 74, 167–176 (2014).
17. Sun, A. et al. GSK-3β controls autophagy by modulating LKB1-AMPK pathway in prostate cancer cells. Prostate 76, 172–183 (2016).
18. Senft, D. & Ronai, Z. A. crosstalk underlies the ER stress response. Trends Biochem. Sci. 40, 141–148 (2015).
19. Brüning, A., Rahmeh, M. & Friese, K. Nelfinavir and bortezomib inhibit mTOR activity via ATF4-mediated sestrin-2 regulation. Mol. Oncol. 7, 1012–1018 (2013).
20. Høyer-Hansen, M. & Jäättelä, M. Connecting endoplasmic reticulum stress to autophagy by unfolded protein response and calcium. Cell Death Differ. 14, 1576–1582 (2007).
21. Natsume, T. et al. A Direct Nanoflow Liquid Chromatography−Tandem Mass Spectrometry System for Interaction Proteomics. Anal. Chem. 74, 4725–4733 (2002).
22. Webber, J. L. & Tooze, S. A. Coordinated regulation of autophagy by p38a MAPK through mAtg9 and p38IP. EMBO J. 29, 27–40 (2010).
23. Liu, X. et al. The p38-Interacting protein (p38IP) regulates G2/M progression by promoting α-Tubulin acetylation via inhibiting ubiquitination-Induced degradation of the acetyltransferase GCN5. J. Biol. Chem. 288, 36648–36661 (2013).
24. Zohn, I. E. et al. p38 and a p38-Interacting Protein Are Critical for Downregulation of E-Cadherin during Mouse Gastrulation. Cell 125, 957–969 (2006).
25. Nagy, Z. et al. The Human SPT20-Containing SAGA Complex Plays a Direct Role in the Regulation of Endoplasmic Reticulum Stress-Induced Genes. Mol. Cell. Biol. 29, 1649–1660 (2009).
26. Dikic, I. Proteasomal and Autophagic Degradation Systems. Annu. Rev. Biochem. 86, 193–224 (2017).
27. Mizushima, N., Yoshimori, T. & Levine, B. Methods in Mammalian Autophagy Research. Cell 140, 313–326 (2010).
28. Milani, M. et al. The role of ATF4 stabilization and autophagy in resistance of breast cancer cells treated with Bortezomib. Cancer Res. 69, 4415–4423 (2009).
29. Young, A. R. J. Starvation and ULK1-dependent cycling of mammalian Atg9 between the TGN and endosomes. J. Cell Sci. 119, 3888–3900 (2006).
30. Longatti, A. et al. TBC1D14 regulates autophagosome formation via Rab11- and ULK1-positive recycling endosomes. J. Cell Biol. 197, 659–675 (2012).
31. Popovic, D. & Dikic, I. TBC1D5 and the AP2 complex regulate ATG9 trafficking and initiation of autophagy. EMBO Rep. 15, 392–401 (2014).
32. Puri, C., Renna, M., Bento, C. F., Moreau, K. & Rubinsztein, D. C. Diverse autophagosome membrane sources coalesce in recycling endosomes. Cell 154, 1285–1299 (2013).
33. Misaki, R., Nakagawa, T., Fukuda, M., Taniguchi, N. & Taguchi, T. Spatial segregation of degradation- and recycling-trafficking pathways in COS-1 cells. Biochem. Biophys. Res. Commun. 360, 580–585 (2007).
34. Orsi, A. et al. Dynamic and transient interactions of Atg9 with autophagosomes, but not membrane integration, are required for autophagy. Mol. Biol. Cell 23, 1860–1873 (2012).
35. Imai, K. et al. Atg9A trafficking through the recycling endosomes is required for autophagosome formation. J. Cell Sci. 129, 3781–3791 (2016).
36. Osawa, T. et al. Atg2 mediates direct lipid transfer between membranes for autophagosome formation. Nat. Struct. Mol. Biol. 26, 281–288 (2019).
37. Gómez‑Sánchez, R. et al. Atg9 establishes Atg2-dependent contact sites between the endoplasmic reticulum and phagophores. J. Cell Biol. 217, 2743–2763 (2018).
38. Knævelsrud, H. et al. Membrane remodeling by the PX-BAR protein SNX18 promotes autophagosome formation. J. Cell Biol. 202, 331–349 (2013).
39. Adams, J. The development of proteasome inhibitors as anticancer drugs. Cancer Cell 5, 417–421 (2004).
40. Vilchez, D. et al. Increased proteasome activity in human embryonic stem cells is regulated by PSMD11. Nature 489, 304–308 (2012).
41. Zhang, Y. et al. Coordinated regulation of protein synthesis and degradation by mTORC1. Nature 513, 440–443 (2014).
42. Vilchez, D. et al. RPN-6 determines C. elegans longevity under proteotoxic stress conditions. Nature 489, 263–268 (2012).
43. Rodriguez, K. A., Edrey, Y. H., Osmulski, P., Gaczynska, M. & Buffenstein, R. Altered composition of liver proteasome assemblies contributes to enhanced proteasome activity in the exceptionally long-lived naked mole-rat. PLoS One 7, (2012).
44. Tonoki, A. et al. Genetic evidence linking age-dependent attenuation of the 26S proteasome with the aging process. Mol. Cell. Biol. 29, 1095–1106 (2009).
45. Sasaki, K. et al. PAC1 gene knockout reveals an essential role of chaperone- mediated 20S proteasome biogenesis and latent 20S proteasomes in cellular homeostasis. Mol. Cell. Biol. 30, 3864–74 (2010).
46. Tomaru, U. et al. Decreased proteasomal activity causes age-related phenotypes and promotes the development of metabolic abnormalities. Am. J. Pathol. 180, 963–972 (2012).
47. Torres, C., Lewis, L. & Cristofalo, V. J. Proteasome inhibitors shorten replicative life span and induce a senescent-like phenotype of human fibroblasts. J. Cell. Physiol. 207, 845–853 (2006).
48. Brehm, A. & Krüger, E. Dysfunction in protein clearance by the proteasome: Impact on autoinflammatory diseases. Semin. Immunopathol. 37, 323–333 (2015).
49. Brehm, A. et al. Additive loss-of-function proteasome subunit mutations in CANDLE/PRAAS patients promote type I IFN production. J. Clin. Invest. 125, 4196–4211 (2015).
50. Arima, K. et al. Proteasome assembly defect due to a proteasome subunit beta type 8 (PSMB8) mutation causes the autoinflammatory disorder, Nakajo- Nishimura syndrome. Proc. Natl. Acad. Sci. 108, 14914–14919 (2011).
51. McDermott, A., Jacks, J., Kessler, M., Emanuel, P. D. & Gao, L. Proteasome- associated autoinflammatory syndromes: advances in pathogeneses, clinical presentations, diagnosis, and management. Int. J. Dermatol. 54, 121–129 (2015).
52. Linton, P. J. & Dorshkind, K. Age-related changes in lymphocyte development and function. Nat. Immunol. 5, 133–139 (2004).
53. Cavanagh, M. M., Weyand, C. M. & Goronzy, J. J. Chronic inflammation and aging: DNA damage tips the balance. Curr. Opin. Immunol. 24, 488–493 (2012).
54. Maue, A. C. et al. T-cell immunosenescence: lessons learned from mouse models of aging. Trends Immunol. 30, 301–305 (2009).
55. Haynes, L. & Swain, S. L. Aged-related shifts in T cell homeostasis lead to intrinsic T cell defects. Semin. Immunol. 24, 350–355 (2012).
56. Shimatani, K., Nakashima, Y., Hattori, M., Hamazaki, Y. & Minato, N. PD-1+ memory phenotype CD4+ T cells expressing C/EBPalpha underlie T cell immunodepression in senescence and leukemia. Proc. Natl. Acad. Sci. U. S. A. 106, 15807–12 (2009).
57. Berges, C. et al. Proteasome inhibition suppresses essential immune functions of human CD4 + T cells. Immunology 124, 234–246 (2008).
58. Yanaba, K. et al. The proteasome inhibitor bortezomib inhibits T cell-dependent inflammatory responses. J. Leukoc. Biol. 88, 117–122 (2010).
59. Saez, I. & Vilchez, D. The mechanistic links between proteasome activity, aging and age-related diseases. Curr. Genomics 15, 38–51 (2014).
60. Kuilman, T., Michaloglou, C., Mooi, W. J. & Peeper, D. S. The essence of senescence. Genes Dev. 24, 2463–2479 (2010).
61. Mizuno, H., Nakanishi, Y., Ishii, N., Sarai, A. & Kitada, K. A signature-based method for indexing cell cycle phase distribution from microarray profiles. BMC Genomics 10, 137 (2009).
62. Hamazaki, J., Hirayama, S. & Murata, S. Redundant roles of Rpn10 and Rpn13 in recognition of ubiquitinated proteins and cellular homeostasis. PLOS Genet. 11, e1005401 (2015).
63. Shi, J. & Petrie, H. T. Activation kinetics and off-target effects of thymus- initiated Cre transgenes. PLoS One 7, e46590 (2012).
64. Carow, B., Gao, Y., Coquet, J., Reilly, M. & Rottenberg, M. E. lck-Driven Cre expression alters T cell development in the thymus and the frequencies and functions of peripheral T cell subsets. J. Immunol. 197, 2261–2268 (2016).
65. Huang, D. W., Sherman, B. T. & Lempicki, R. A. Bioinformatics enrichment tools: Paths toward the comprehensive functional analysis of large gene lists. Nucleic Acids Res. 37, 1–13 (2009).
66. Baumeister, W., Walz, J., Zühl, F. & Seemüller, E. The proteasome: Paradigm of a self-compartmentalizing protease. Cell 92, 367–380 (1998).
67. Kaneko, T. et al. Assembly pathway of the mammalian proteasome base subcomplex is mediated by multiple specific chaperones. Cell 137, 914–925 (2009).
68. Ramos, P. C. & Dohmen, R. J. PACemakers of proteasome core particle assembly. Structure 16, 1296–1304 (2008).
69. Kusmierczyk, A. R., Kunjappu, M. J., Funakoshi, M. & Hochstrasser, M. A multimeric assembly factor controls the formation of alternative 20S proteasomes. Nat. Struct. Mol. Biol. 15, 237–244 (2008).
70. Murata, S., Yashiroda, H. & Tanaka, K. Molecular mechanisms of proteasome assembly. Nat. Rev. Mol. Cell Biol. 10, 104–115 (2009).
71. Kalim, K. W., Basler, M., Kirk, C. J. & Groettrup, M. Immunoproteasome Subunit LMP7 Deficiency and Inhibition Suppresses Th1 and Th17 but Enhances Regulatory T Cell Differentiation. J. Immunol. 189, 4182–4193 (2012).
72. Oki, S. et al. Integrative analysis of transcription factor occupancy at enhancers and disease risk loci in noncoding genomic regions. bioRxiv (2018). doi:https://doi.org/10.1101/262899
73. Kappelmann, M., Bosserhoff, A. & Kuphal, S. AP-1/c-Jun transcription factors: Regulation and function in malignant melanoma. Eur. J. Cell Biol. 93, 76–81 (2014).
74. Li, P. et al. BATF-JUN is critical for IRF4-mediated transcription in T cells. Nature 490, 543–546 (2012).
75. Gorentla, B. K. & Zhong, X.-P. T cell receptor signal transduction in T lymphocytes. J. Clin. Cell. Immunol. 2012, 5 (2012).
76. Tomita, T. et al. Specific modification of aged proteasomes revealed by tag- exchangeable knock-in mice. Mol. Cell. Biol. 39, (2018).
77. Motosugi, R. & Murata, S. Dynamic regulation of proteasome expression. Front. Mol. Biosci. 6, 4–11 (2019).
78. Lee, S. et al. Involvement of the Nrf2-proteasome pathway in the endoplasmic reticulum stress response in pancreatic β -cells. Toxicol. Appl. Pharmacol. 264, 431–438 (2012).
79. Pickering, A. M., Linder, R. A., Zhang, H., Forman, H. J. & Davies, K. J. A. Nrf2-dependent induction of proteasome and Pa28αβ regulator are required for adaptation to oxidative stress. J. Biol. Chem. 287, 10021–10031 (2012).
80. Vangala, J. R., Dudem, S., Jain, N. & Kalivendi, S. V. Regulation of PSMB5 protein and β subunits of mammalian proteasome by constitutively activated signal transducer and activator of transcription 3 (STAT3). J. Biol. Chem. 289, 12612–12622 (2014).
81. Lu, L. et al. Ameliorating replicative senescence of human bone marrow stromal cells by PSMB5 overexpression. Biochem. Biophys. Res. Commun. 443, 1182– 1188 (2014).
82. Shin, S.-W. et al. Mouse zygote-specific proteasome assembly chaperone important for maternal-to-zygotic transition. Biol. Open 2, 170–182 (2013).
83. Tahir, S. et al. A CD153+ CD4+ T follicular cell population with cell-senescence features plays a crucial role in lupus pathogenesis via osteopontin production. J. Immunol. 194, 5725–5735 (2015).
84. Xu, H. et al. The CCAAT box-binding transcription factor NF-Y regulates basal expression of human proteasome genes. Biochim. Biophys. Acta - Mol. Cell Res. 1823, 818–825 (2012).
85. Pahlavani, M. A. & Vargas, D. M. Age-related decline in activation of calcium/calmodulin-dependent phosphatase calcineurin and kinase CaMK-IV in rat T cells. Mech. Ageing Dev. 112, 59–74 (1999).
86. Trebilcock, G. U. & Ponnappan, U. Nuclear factor-κB induction in CD45RO+ and CD45RA+ T cell subsets during aging. Mech. Ageing Dev. 102, 149–163 (1998).
87. Shirakawa, K. et al. Obesity accelerates T cell senescence in murine visceral adipose tissue. 126, (2016).
88. Tanashi, N., Murakami, Y. & Minami, Y. Hybrid proteasomes. J. Biol. Chem 275, 14336–14345 (2000).
89. Komatsu, M. et al. Homeostatic Levels of p62 Control Cytoplasmic Inclusion Body Formation in Autophagy-Deficient Mice. Cell 131, 1149–1163 (2007).
90. Tamura, H., Shibata, M., Koike, M., Sasaki, M. & Uchiyama, Y. Atg9A protein, an autophagy-related membrane protein, is localized in the neurons of mouse brains. J. Histochem. Cytochem. 58, 443–453 (2010).
91. Kageyama, S. et al. The LC3 recruitment mechanism is separate from Atg9L1- dependent membrane formation in the autophagic response against Salmonella. Mol. Biol. Cell 22, 2290–2300 (2011).
92. Schindelin, J. et al. Fiji: An open-source platform for biological-image analysis. Nat. Methods 9, 676–682 (2012).
93. Hirayama, S. et al. Nuclear export of ubiquitinated proteins via the UBIN-POST system. Proc. Natl. Acad. Sci. 201711017 (2018). doi:10.1073/pnas.1711017115
94. Hayatsu, N. et al. Analyses of a mutant Foxp3 allele reveal BATF as a critical transcription factor in the differentiation and accumulation of tissue regulatory T cells. Immunity 47, 268–283.e9 (2017).
95. Hirano, Y. et al. A heterodimeric complex that promotes the assembly of mammalian 20S proteasomes. Nature 437, 1381–1385 (2005).
論文の公開元へ
